EMJ GOLD

Filter Advertise With Us

GLP-1s: Cannes, culture and lessons from oncology

Claire Gillis, CEO, VML Health, explores how GLP-1s could transform medicine, echoing the cancer care revolution.

GLP-1s: Cannes, culture and lessons from oncology

Claire Gillis, CEO, VML Health, explores how GLP-1s could transform medicine, echoing the cancer care revolution.

Ester in ’t Groen, Johnson & Johnson Innovative Medicine

One to watch: Multiple myeloma at EHA 2026

Ester in ’t Groen, TA Head, Haematology, J&J Innovative Medicine, discusses how treatment advances are transforming care.

The big picture in haematology at EHA 2026

Aliya Omer, VP, Global Head, Haematology Franchise, AstraZeneca, discusses haematological malignancies.

5 minutes with Dr Siddharth Jain, Takeda

Siddharth, Head, Global Medical Unit for Growth & Launch Brands in Rare Diseases, Takeda, discusses his role and career.

5 minutes with Muriel O'Byrne, Regeneron

To celebrate World Clinical Trials Day 2026, Muriel unpacks the top challenges and opportunities in the landscape today.

Outernet Building, London

5 things you need to know from WIRED Health 2026

From Lord Darzi on AMR to LinkedIn’s Reid Hoffman on AI drug discovery, the event had plenty to unpack for pharma.

Catalyst of Pharma - Andrew Menzies-Gow

AZ’s Andrew Menzies-Gow on a new era for respiratory care

In this interview, Andrew Menzies-Gow, AstraZeneca, explores how earlier diagnosis could transform respiratory care.

Dr Henar Hevia on navy blue background

Dr Henar Hevia talks to data, decision-making and cancer care

Columnist Dr Henar Hevia, J&J Innovative Medicine, explores how oncology’s future hinges on smarter use of data.

Loading posts...

1 2 3 … 37 Next »